ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

0.6831
0.0221
( 3.34% )
업데이트: 22:30:00

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.6831
매수가
0.662
매도가
0.6933
거래량
13,321
0.6831 일간 변동폭 0.6831
0.63 52주 범위 3.1399
market_cap
전일 종가
0.661
개장가
0.6831
최근 거래 시간
44
@
0.6899
마지막 거래 시간
22:30:01
재정 규모
US$ 9,100
VWAP
0.6831
평균 볼륨(3m)
882,494
발행 주식
68,398,826
배당수익률
-
주가수익률
-0.38
주당순이익(EPS)
-1.72
매출
-
순이익
-117.86M

Vor Biopharma Inc 정보

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker VOR. The last closing price for Vor Biopharma was US$0.66. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.63 to US$ 3.1399.

Vor Biopharma currently has 68,398,826 shares in issue. The market capitalisation of Vor Biopharma is US$45.21 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.38.

VOR 최신 뉴스

Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Han Choi, M.D., LL.M., as its...

New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with...

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0716-9.48721346230.75470.76650.638403500.6653019CS
4-0.2759-28.76955161630.9591.190.6318532310.90722707CS
12-0.2969-30.29591836730.981.190.638824940.9006543CS
26-1.4669-68.22790697672.152.230.635603991.05836327CS
52-1.4269-67.62559241712.113.13990.633940511.36270993CS
156-14.8769-95.609897172215.5618.5150.632175723.2342972CS
260-41.3369-98.374345549742.0263.620.632127137.41781842CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AALAmerican Airlines Group Inc
US$ 10.82
(0.00%)
943.72k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.41
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.92
(0.00%)
39
AACGATA Creativity Global
US$ 0.88
(0.00%)
205
AALAmerican Airlines Group Inc
US$ 10.82
(0.00%)
954.92k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.41
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.92
(0.00%)
39
AACGATA Creativity Global
US$ 0.88
(0.00%)
205
NCNCnoco noco Inc
US$ 0.1326
(0.00%)
82.17M
VEVVicinity Motor Corporation
US$ 0.1448
(0.00%)
30.02M
BENFBeneficient
US$ 1.19
(0.00%)
29.19M
PEVPhoenix Motor Inc
US$ 0.3475
(0.00%)
20.24M
SQQQProShares UltraPro Short QQQ
US$ 7.71
(0.00%)
16.07M

VOR Discussion

게시물 보기
PonkenPlonken PonkenPlonken 3 주 전
The buyers of all these shares arent going anywhere. Waiting for it to unfold.
All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal
👍️0
PonkenPlonken PonkenPlonken 4 주 전
remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.
👍️0
PonkenPlonken PonkenPlonken 4 주 전
Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.
👍️0
glenn1919 glenn1919 4 주 전
VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 월 전
VOR new 52 week low
👍️0
Monksdream Monksdream 3 월 전
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 3 월 전
Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
👍️0
Monksdream Monksdream 3 월 전
GNPX new 52 week low

👍️0
PonkenPlonken PonkenPlonken 3 월 전
Im starting to think someone just buys them out.
Interesting action yesterday.
👍️0
Monksdream Monksdream 4 월 전
VOR new 52 week low
👍️0
Monksdream Monksdream 4 월 전
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 5 월 전
elevated volume for quite some time now.
👍️0
PonkenPlonken PonkenPlonken 5 월 전
https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
👍️0
Monksdream Monksdream 6 월 전
VORBunder $2
👍️0
glenn1919 glenn1919 7 월 전
VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0

최근 히스토리

Delayed Upgrade Clock